Detalhe da pesquisa
1.
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial.
Lancet
; 403(10424): 379-390, 2024 Jan 27.
Artigo
Inglês
| MEDLINE | ID: mdl-38109916
2.
Methods Article for a Study Protocol: Study Design and Baseline Characteristics for Aldosterone Synthase Inhibition in Chronic Kidney Disease.
Am J Nephrol
; 55(2): 262-272, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-37903483
3.
Aldosterone synthase inhibitor (BI 690517) therapy for people with diabetes and albuminuric chronic kidney disease: A multicentre, randomized, double-blind, placebo-controlled, Phase I trial.
Diabetes Obes Metab
; 26(6): 2128-2138, 2024 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-38497241
4.
Predictors of Atrial Fibrillation Development in Patients With Embolic Stroke of Undetermined Source: An Analysis of the RE-SPECT ESUS Trial.
Circulation
; 144(22): 1738-1746, 2021 11 30.
Artigo
Inglês
| MEDLINE | ID: mdl-34649459
5.
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source.
N Engl J Med
; 380(20): 1906-1917, 2019 05 16.
Artigo
Inglês
| MEDLINE | ID: mdl-31091372
6.
Antithrombotic Treatment of Embolic Stroke of Undetermined Source: RE-SPECT ESUS Elderly and Renally Impaired Subgroups.
Stroke
; 51(6): 1758-1765, 2020 06.
Artigo
Inglês
| MEDLINE | ID: mdl-32404035
7.
Dabigatran vs. Aspirin for Secondary Prevention After Embolic Stroke of Undetermined Sourceã- Japanese Subanalysis of the RE-SPECT ESUS Randomized Controlled Trial.
Circ J
; 84(12): 2286-2295, 2020 11 25.
Artigo
Inglês
| MEDLINE | ID: mdl-33132228
8.
Predictors of Recurrent Stroke After Embolic Stroke of Undetermined Source in the RE-SPECT ESUS Trial.
J Am Heart Assoc
; 11(11): e023545, 2022 06 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35656979
9.
Safety, tolerability and clinical pharmacology of dabigatran etexilate in adolescents. An open-label phase IIa study.
Thromb Haemost
; 116(3): 461-71, 2016 08 30.
Artigo
Inglês
| MEDLINE | ID: mdl-27357738
10.
Design of Randomized, double-blind, Evaluation in secondary Stroke Prevention comparing the EfficaCy and safety of the oral Thrombin inhibitor dabigatran etexilate vs. acetylsalicylic acid in patients with Embolic Stroke of Undetermined Source (RE-SPECT ESUS).
Int J Stroke
; 10(8): 1309-12, 2015 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-26420134
11.
Health-related quality of life in women with polycystic ovary syndrome, a self-administered questionnaire, was validated.
J Clin Epidemiol
; 57(12): 1279-87, 2004 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-15617954